BioVie Inc.
BIVI · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $13,666 | $18,314 | $139,989 | $35,670 |
| - Cash | $17,545 | $23,844 | $19,461 | $18,642 |
| + Debt | $350 | $6,111 | $14,420 | $12,265 |
| Enterprise Value | -$3,529 | $581 | $134,948 | $29,293 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$229 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$16,980 | -$31,950 | -$45,726 | -$27,024 |
| % Margin | – | – | – | – |
| Net Income | -$17,542 | -$32,121 | -$50,256 | -$26,084 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.12 | -73.05 | -154.7 | -106 |
| % Growth | 83.4% | 52.8% | -45.9% | – |
| Operating Cash Flow | -$19,025 | -$27,945 | -$40,253 | -$18,991 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$19,025 | -$27,945 | -$40,253 | -$18,991 |